Abstract
Background
Lymph node status is important in staging colorectal cancer (CRC). Presence of metastatic nodes differentiates stage III from stage II. The role of adjuvant therapy is still unclear in stage II CRC. Inadequate node sampling may result in inaccurate staging.
Method
Records of 131 patients with stages II and III CRC who underwent curative resection, having five or more lymph nodes harvested from the specimen, were prospectively followed up and analyzed. The Kaplan–Meier method was used to analyze survival, based on groups of serially ascending values of lymph nodes harvested. Regression analysis was performed by Cox proportional hazards ratio model with right-censored CRC survival data at a 10 % significance level. The effect of nodal harvest on survival was adjusted for age, sex, preoperative carcinoembryonic antigen (CEA) level, neoadjuvant chemoradiation, pathological tumor stage, histological type, differentiation, margin positivity, angioinvasion, perineural invasion, and lymphovascular infiltration.
Results
The total population showed improved survival with 14 or more nodes harvested (p= 0.005). For both rectal (n= 83; p= 0.03) and colon cancers (n= 46; p= 0.08), most significant survival benefits were seen with over 14 nodes harvested, irrespective of the stage. With multiple regression analysis, advanced age (p= 0.003), male sex (p= 0.017), lymphovascular infiltration (p= 0.015), and preoperative CEA levels (p= 0.096) were found to be other significant factors. The lymph node effect remained significant (HR = 0.19, p= 0.004) after adjusting for the above factors.
Conclusion
A lymph node harvest of 14 or more resulted in better survival outcome from CRC in this population. Staging of the disease could be accurate with increased nodal harvesting.
Similar content being viewed by others
References
Grothy A. Risk assessment in stage II colon cancer: to treat or not to treat. Oncology (Williston Park). 2010;24 Suppl 1:1–2.
O’Connell M, Maillard JA, Kahn MJ, et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol. 1997;15:246–50.
O’Connell M, Laurie JA, Kahn MJ, et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol. 1998;16:295–300.
Benson AB III, Schrag D, Somerfield MR, et al. American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22:3408–19.
Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American pathologists consensus statement 1999. Arch Pathol Lab Med. 2000;124:979–94.
Engstrom PF, Benson AB III, Saltz L. National comprehensive cancer network: colon cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2003;1:40–53.
Obrocea FL, Sajin M, Marinescu EC, Stoica D. Colorectal cancer and the 7th revision of the TNM staging system: review of changes and suggestions for uniform pathologic reporting. Rom J Morphol Embryol. 2011;52:537–44.
Pheby DF, Levine DF, Pitcher RW, Shepherd NA. Lymph node harvests directly influence the staging of colorectal cancer: evidence from a regional audit. J Clin Pathol. 2004;57:43–7.
Ratto C, Sofo L, Ippoliti M, et al. Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum. 1999;42:143–54.
Vather R, Sammour T, Kahokehr A, Connolly AB, Hill AG. Lymph node evaluation and long-term survival in stage II and stage III colon cancer: a national study. Ann Surg Oncol. 2009;16:585–93.
Berberoglu M. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer. Hepatogastroenterology. 2004;51:1689–93.
Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006;244:602–10.
The Commission on Cancer (CoC) of the American College of Surgeons. Colon Cancer Measures submitted by the CoC to the National Quality Forum (NQF) and endorsed by the NQF in April 2007. In: American College of Surgeons. Cancer Program. Available via http://www.facs.org/cancer/qualitymeasures.html. Accessed May 2013.
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Colon Cancer Version 3.2013. 2013;National Comprehensive Cancer Network. Available via http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site. Accessed 15 May 2013.
Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97:219–25.
Johnson PM, Malatjalian D, Porter GA. Adequacy of nodal harvest incolorectal cancer: a consecutive cohort study. J Gastrointest Surg. 2002;6:883–8.
Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal specimens spanning 45 years. Recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol. 2002;26:179–89.
Leibl S, Tsybrovskyy O, Denk H. How many lymph nodes are necessary to stage early and advanced adenocarcinoma of the sigmoid colon and upper rectum? Virchows Arch. 2003;443:133–8.
Luna-Pérez P, Rodríguez-Ramírez S, Alvarado I, et al. Prognostic significance of retrieval lymph nodes per specimen in resected rectal adenocarcinoma after chemoradiation therapy. Arch Med Res. 2003;34:281–6.
Berberoglu U. Prognostic significance of total lymph node number in patients with T1-4 N0 M0 colorectal cancer. Hepatogastroenterology. 2004;51:1689–93.
Rivadulla-Serrano MI, Martínez-Ramos D, Armengol-Carrasco M, et al. Impact of the total number of harvested lymph nodes after colon cancer resections on survival in patients without involved lymph node. Rev Esp Enferm Dig. 2010;102:296–301.
Peeples C, Shellnut J, Wasvary H, Riggs T, Sacksner J. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant? Dis Colon Rectum. 2010;53:1517–23.
Wijesuriya SRE, Deen KI, Hewavisenthi J, Balawardana J, Perera M. Neoadjuvant therapy for rectal cancer down-stages the tumor but reduces lymph node harvest significantly. Surg Today. 2005;35:442–5.
Klos CL, Bordeianou LG, Sylla P, Chang Y, Berger DL. The prognostic value of lymph node ratio after neoadjuvant chemoradiation and rectal cancer surgery. Dis Colon Rectum. 2011;54:171–5.
Barresi V, Reggiani Bonetti L, Vitarelli E, Di Gregorio C, Ponz de Leon M, Barresi G. Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases. Am J Surg Pathol. 2012;36:66–72.
Porter GA, Urquhart R, Bu J, Johnson P, Grunfeld E. The impact of audit and feedback on nodal harvest in colorectal cancer. BMC Cancer. 2011;11:2.
Conflict of interest
None of the authors have conflicts of interest to be declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chandrasinghe, P.C., Ediriweera, D.S., Hewavisenthi, J. et al. The total number of lymph nodes harvested is associated with better survival in stages II and III colorectal cancer. Indian J Gastroenterol 33, 249–253 (2014). https://doi.org/10.1007/s12664-013-0406-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12664-013-0406-2